211
Participants
Start Date
October 15, 2019
Primary Completion Date
September 21, 2022
Study Completion Date
January 17, 2023
EB01 Cream Placebo
Vehicle Cream containing 0% EB w/w applied BID
EB01 Cream 0.2%
EB01 Cream containing 0.2% EB01 w/w applied BID
EB01 Cream 1.0%
EB01 Cream containing 1.0% EB01 w/w applied BID
EB01 Cream 2.0%
EB01 Cream containing 2.0% EB01 w/w applied BID
JUVA Skin & Laser Center, New York
Foxhall Dermatology, Washington D.C.
West Virginia Research Institute, Morgantown
UNC Dermatology and Skin Cancer Center, Chapel Hill
Miami Dade Medical Research Institute, LLC, Miami
Gold Coast Dermatology, Delray Beach
Forefront Dermatology, Louisville
Bexly Dermatology, Bexley
Apex Clinical Research Center, LLC, Mayfield Heights
The Dermatology Centre of Indiana, Plainfield
Oakland Hills Dermatology P.C., Auburn Hills
Associated Skin Care Specialists, Fridley
The Dermatology Clinic, Baton Rouge
Ark Clinical Research, Long Beach
Lynderm Research Inc., Markham
Lead Sponsor
Collaborators (1)
JSS Medical Research Inc.
INDUSTRY
Edesa Biotech Inc.
INDUSTRY